Newsroom - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to ...
Edwards Lifesciences to Sell Critical Care to BD
Jun 3, 2024 · IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin ...
Press Releases - Edwards Lifesciences
Oct 17, 2024 · Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
BD Completes Acquisition of Critical Care from Edwards Lifesciences
Sep 3, 2024 · BD Completes Acquisition of Critical Care from Edwards Lifesciences. Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools. Combination of leading monitoring and infusion platforms enables future innovation opportunities for closed–loop monitoring ...
Edwards Lifesciences Completes Sale of Critical Care
Nov 7, 2024 · IRVINE, Calif.-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4.2 billion in an all-cash transaction.
Edwards Lifesciences Corporation (EW) Latest Stock News
Get the latest Edwards Lifesciences Corporation (EW) stock news and headlines to help you in your trading and investing decisions.
BD to Acquire Edwards Lifesciences' Critical Care Product Group …
Jun 3, 2024 · BD today announced a definitive agreement to acquire Edwards Lifesciences' Critical Care product group, a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new...
Edwards Lifesciences to spin off critical care unit to focus on heart ...
Dec 7 (Reuters) - Edwards Lifesciences (EW.N) said on Thursday it would spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business.
News - Edwards Air Force Base
Nov 7, 2024 · A trio of A-29 Super Tucano aircraft recently arrived at Edwards Air Force Base to join a unique fleet at the Air Force Test Pilot School. The arrival marks the first newly assigned aircraft for the school in nearly 30 years.
Edwards Lifesciences Corp - Edwards’ EVOQUE Valve …
Feb 2, 2024 · Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).